Please login to the form below

Not currently logged in
Email:
Password:

meningitis

This page shows the latest meningitis news and features for those working in and with pharma, biotech and healthcare.

GSK doses first patients in phase 3 meningitis vaccine trial

GSK doses first patients in phase 3 meningitis vaccine trial

Currently, there are no five-in-one combination vaccines for meningitis available anywhere in the world. ... Adolescents and young adults are more likely to contract meningitis due to their close contact with each other.

Latest news

More from news
Approximately 15 fully matching, plus 58 partially matching documents found.

Latest Intelligence

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK. ... In a campaign first, Pfizer granted full creative licence to ten

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    One example is the Teddy Bears’ Picnic on the banks of the river Thames near Tower Bridge, which aimed to raise awareness of bacterial meningitis.

  • Pharma deals in June 2015 Pharma deals in June 2015

    When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in ... As a result GSK has sold two of its own

  • Pharma deals during July 2014 Pharma deals during July 2014

    The transaction includes two vaccines currently marketed outside the US and primarily in Europe: NeisVac-C, a vaccine against group C meningococcal meningitis (MenC), and FSME-IMMUN against tick-borne encephalitis

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. Also included in the meningitis “goodie

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics